HS
PFE icon

Horan Securities’s Pfizer PFE Stock Holding History

Horan Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,924
Closed -$181K – 488
2023
Q2 		$181K Buy
4,924
+257
+6% +$10K 0.08% 125
2023
Q1 		$190K Buy
4,667
+624
+15% +$27K 0.1% 112
2022
Q4 		$207K Buy
4,043
+161
+4% +$7.72K 0.12% 93
2022
Q3 		$170K Buy
3,882
+16
+0.4% +$777 0.1% 102
2022
Q2 		$196K Buy
3,866
+85
+2% +$4.33K 0.12% 94
2022
Q1 		$196K Buy
3,781
+14
+0.4% +$726 0.12% 82
2021
Q4 		$222K Buy
+3,767
New +$187K 0.13% 79
2021
Q2 		$139K Buy
3,558
+321
+10% +$12.5K 0.1% 100
2021
Q1 		$117K Sell
3,237
-43
-1% -$1.53K 0.1% 79
2020
Q4 		$121K Buy
3,280
+800
+32% +$29.3K 0.1% 72
2020
Q3 		$86K Buy
2,480
+271
+12% +$9.5K 0.09% 72
2020
Q2 		$69K Buy
2,209
+44
+2% +$1.5K 0.08% 61
2020
Q1 		$67K Buy
+2,165
New +$73.8K 0.09% 54
2019
Q4 		– Sell
-2,142
Closed -$73K – 172
2019
Q3 		$73K Sell
2,142
-99
-4% -$3.6K 0.08% 60
2019
Q2 		$92K Buy
2,241
+521
+30% +$20.7K 0.1% 47
2019
Q1 		$69K Buy
1,720
+9
+0.5% +$360 0.07% 49
2018
Q4 		$69K Buy
1,711
+9
+0.5% +$374 0.08% 46
2018
Q3 		$72K Buy
1,702
+8
+0.5% +$308 0.07% 41
2018
Q2 		$60K Buy
1,694
+11
+0.7% +$376 0.06% 50
2018
Q1 		$58K Buy
1,683
+10
+0.6% +$344 0.05% 51
2017
Q4 		$58K Buy
1,673
+9
+0.5% +$307 0.05% 52
2017
Q3 		$57K Buy
1,664
+9
+0.5% +$289 0.06% 50
2017
Q2 		$52K Buy
1,655
+12
+0.7% +$378 0.06% 48
2017
Q1 		$53K Buy
+1,643
New +$51.8K 0.06% 46
2016
Q4 		– Sell
-1,442
Closed -$45K – 116
2016
Q3 		$45K Buy
+1,442
New +$48.2K 0.06% 43

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Horan Securities's PFE Position: Q3 2023 in Review

Horan Securities sold out of Pfizer (PFE) in Q3 2023, closing a stake of 4,924 shares — an estimated $181K sold.

Horan Securities first reported a position in PFE in Q3 2016 and held it in 25 quarters. The position peaked at $222K in Q4 2021. 2,928 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • Horan Securities reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 4,924 Pfizer shares in Q3 2023, an estimated $181K.
  • Horan Securities first reported a position in Pfizer in Q3 2016 and held it in 25 quarters.
  • Horan Securities's Pfizer position peaked at $222K in Q4 2021.
  • 2,928 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.